Job/Unit: O30463
/KAP1
Date: 16-07-13 18:43:51
Pages: 16
V. Schmitt, S. Moschel, H. Detert
FULL PAPER
3
3
(CDCl3, 400 MHz, 25 °C): δ = 8.15 (d, J = 7.7 Hz, 4 H), 8.10 (d,
H vin), 6.61 (d, J = 8.4 Hz, 4 H, 3-H, 5-H Ph), 3.76–3.60 (m, 40
H, CH2) ppm. 13C NMR (CDCl3, 75 MHz): δ = 149.4, 147.7, 145.0
3J = 15.7 Hz, 2 H), 7.91 (m, 4 H, 3-H), 7.74 (d, 3J = 7.74 Hz, 4
H), 7.63 (m, 4 H), 7.60–7.56 (m, 6 H), 7.49–7.45 (m, 6 H), 7.42 (dt, (C-4 Ph, C-3, C-6, C-2, C-5 Pz), 138.7 (C-1 Ph-p), 134.2 (C-2 vin),
3J = 8.2, 4J = 1.2 Hz, 4 H), 7.30 (dt, 3J = 7.7, 4J = 1.3 Hz, 4
129.9 (C-2, C-6 Ph-p), 128.8, 128.6, 128.3 (C-2, C-6 Ph, C-3, C-4,
H) ppm. 13C NMR (CDCl3, 75 MHz, 25 °C): δ = 150.4, 145.0, C-5 Ph-p), 124.9 (C-1 Ph), 119.5 (C-1 vin), 111.4 (C-3, C-5 Ph),
140.6, 138.0, 137.7, 135.9, 133.9, 130.0, 129.2, 128.7, 128.6, 127.1, 71.3, 70.2, 70.1 (OCH2), 68.4 (N-CH2CH2), 52.6 (NCH2) ppm. IR
126.0, 124.8, 123.5, 120.3, 120.1, 109.8 ppm. IR (KBr): ν = 3055,
(ATR): ν = 2853, 1595, 1517, 1381, 1349, 1182, 1116, 958, 807,
˜
˜
1624, 1600, 1514, 1478, 1451, 1361, 1316, 1228, 1169, 1138, 825,
748, 724, 700, 623 cm–1. MS (FD): m/z (%) = 383.2 (6) [M]2+, 766.2
(100) [M]+. C56H38N4 (766.93): calcd. C 87.79, H 4.99, N 7.31;
found C 87.46, H 4.71, N 7.04.
762, 699 cm–1. MS (FD): m/z (%) = 870.3 (100) [M]+. C52H62N4O8
(871.08): calcd. C 71.70, H 7.17, N 6.43; found C 71.66, H 7.07, N
6.34.
(E,E)-2,5-Bis[2-(4-hexyloxyphenyl)ethenyl]-3,6-di(1-naphthyl)-
pyrazine (7): According to the procedure for 1, a solution of 17d
(150 mg, 0.42 mmol), 18f (190 mg, 0.92 mmol), and KOtBu
(190 mg, 1.69 mmol) in DMF (30 mL) gave 85 mg (0.12 mmol,
29 %) of bright-yellow needles with m.p. 156–158 °C. 1H NMR
(E,E)-2,5-Bis{2-[4-(dipropylamino)phenyl]ethenyl}-3,6-diphenyl-
pyrazine (5): According to the procedure for 1, a solution of 17a
(150 mg, 0.58 mmol), 18d (260 mg, 1.27 mmol), and KOtBu
(250 mg, 2.23 mmol) in DMF (25 mL) gave 210 mg (0.33 mmol,
57%) of bright-orange crystals with m.p. 184–185 °C. 1H NMR
3
(CDCl3, 400 MHz, 25 °C): δ = 8.04 (d, J = 8.2 Hz, 2 H, 4-H Np),
3
7.99 (d, 3J = 8.0, 4J = 1 Hz, 2 H, 5-H Np), 7.86 (br. d, 3J = 8.0 Hz,
(CDCl3, 400 MHz, 25 °C): δ = 7.86 (d, J = 15.5 Hz, 2 H, 2-H, 2-
3
3
H vin), 7.88–7.86 (m, 4 H, 2-H, 6-H Ph-p), 7.58–7.49 (m, 6 H, 3-
2 H, 8-H Np), 7.75 (d, J = 15.7 Hz, 2 H, 2-H vin), 7.71 (br. d, J
3
3
H, 4-H, 5-H Ph-p), 7.37 (d, J = 8.9 Hz, 4 H, 2-H, 6-H Ph), 7.14
= 7.4 Hz, 2 H, 2-H Np), 7.67 (t, J = 7.4 Hz, 2 H, 3-H Np), 7.55
3
3
3
4
3
(d, J = 15.5 Hz, 2 H, 1-H vin), 6.60 (d, J = 8.9 Hz, 4 H, 3-H, 5-
H Ph), 3.27 (t, 8 H, NCH2), 1.63 (m, 8 H, CH2), 0.94 (t, 12 H,
CH3) ppm. 13C NMR (CDCl3, 75 MHz, 25 °C): δ = 149.3 (C-4 Ph),
148.3 (C-3, C-6 Pz), 144.9 (C-2, C-5 Pz), 138.8 (C-1 Ph-p), 134.3
(C-2 vin), 129.9 (C-2, C-6 Ph-p), 128.7 (C-3, C-5 Ph-p), 128.5 (C-
2,C-6 Ph), 128.3 (C-4 Ph-p), 124.6 (C-1 Ph), 119.1 (C-1 vin), 111.4
(C-3, C-5 Ph), 52.8 (NCH2), 20.5 (CH2), 11.4 (CH3) ppm. IR
(dt, J = 8.0, J = 1.2 Hz, 2 H, 6-H Np), 7.50 (br. t, J = 7.0 Hz,
3
3
2 H, 7-H Np), 7.13 (d, J = 8.8 Hz, 4 H, 2-H, 6-H Ph), 6.76 (d, J
3
= 15.7 Hz, 2 H, 1-H vin), 6.69 (d, J = 8.8 Hz, 4 H, 3-H, 5-H Ph),
3.98 (t, 4 H, OCH2), 1.70 (m, 4 H, β-CH2), 1.38 (m, 4 H, CH2),
1.27 (m, 8 H, CH2), 0.86 (t, 6 H, CH3) ppm. 13C NMR (CDCl3,
75 MHz, 25 °C): δ = 159.4 (C-4 Ph), 150.4 (C-3, C-6 Pz), 147.0 (C-
2, C-5 Pz), 135.9 (C-1 Np), 134.4 (C-2 vin), 133.9 (C-4a Np), 132.0
(C-8a Np), 129.3 (C-4 Np), 129.2 (C-1 Ph), 128.6 (C-2, C-6 Ph),
128.4 (C-2 Np), 128.3 (C-5 Np), 126.7 (C-7 Np), 126.2 (C-8 Np),
126.0 (C-6 Np), 125.4 (C-3 Np), 121.5 (C-1 vin), 114.5 (C-3, C-5
Ph), 67.9 (OCH2), 31.5 (β-CH2), 29.1, 25.6, 22.6 (CH2), 14.0
(KBr): ν = 2960, 2931, 2872, 1598, 1519, 1380, 1365, 1238, 1183,
˜
1136, 809, 700 cm–1. MS (FD): m/z (%) = 633.9 (100) [M]+. HRMS
(ESI): calcd. for C44H51N4 635.4114; found 635.4095.
X-ray Structure Determination of 5: Performed with an Enraf–Non-
ius Turbo-Cad 4 diffractometer equipped with a rotating anode
(CH ) ppm. IR (ATR): ν = 2923, 2852, 1603, 1572, 1245, 1174,
˜
3
1025, 970, 823, 799, 771, 667 cm–1. MS (FD): m/z (%) = 737.1 (100)
[M]+. C52H52N2O2 (736.98l): calcd. C 84.75, H 7.11, N 3.80; found
C 84.40, H 7.69, N 3.51.
using a red block. Crystal data: C44H50N4, M 635 g mol–1
,
3
¯
0.1ϫ0.36ϫ0.56 mm , triclinic, space group: P1, Mo-Kα, graphite-
monochromated 1.54180 Å, T = 193 K, unit cell dimensions: a =
9.2287(10), b = 13.058(14), c = 16.610(2) Å, α = 100.300(2), β =
(E,E)-2,5-Bis{2-[4-(dipropylamino)phenyl]ethenyl}-3,6-di(1-
naphthyl)pyrazine (8): According to the procedure for 1, a solution
of 17d (150 mg, 0.42 mmol), 18d (190 mg, 0.92 mmol), and KOtBu
(186 mg, 1.66 mmol) in DMF (40 mL) gave 65 mg (0.088 mmol,
21 %) of an amorphous orange solid with m.p. 202–203 °C. 1H
105.007(2), γ = 102.174(2)°, V = 1831.3(6) Å3, z = 2, dcalcd.
=
1.151 gcm–3, absorption μ = 0.07 mm–1, the θ range for data collec-
tion was 2–26°, index ranges: –11Յ hՅ 10, –16Յ kՅ 15, –20Յ lՅ
19. Number of reflections collected: 13155; independent reflections:
6871 (Rint = 0.0216). The structure was solved by direct methods
(program SIR92, refinement by SHELXL97).[48] Structure refine-
ment was performed by full-matrix least-squares methods on 437
3
NMR (CDCl3, 400 MHz, 25 °C): δ = 8.03 (d, J = 8.2 Hz, 2 H, 4-
3
4
H Np), 8.00 (dd, J = 8.1, J = 1.1 Hz, 2 H, 5-H Np), 7.92 (br. d,
3J = 8.0 Hz, 2 H, 8-H Np), 7.74 (br. d, J = 6.7 Hz, 2 H, 1-H vin),
3
parameters, weighted refinement: w = 1/[σ2(Fo2) + (0.0631P)2
+
3
7.70 (d, J = 15.6 Hz, 2 H, 2-H vin), 7.67 (t, 2 H, 3-H Np), 7.56
0.32P] with P = [max(Fo2,0) + 2Fo2]/3 and hydrogen atoms located
from difference Fourier synthesis and refined isotropically as-
suming a riding motion model, non-hydrogen atoms improved by
anisotropic refinement. Goodness-of-fit on S = 1.026, maximal
range of parameters 0.001ϫe.s.d, final R indices: R1 = 0.0490, wR2
= 0.1378, the final difference Fourier map showed minimum and
maximum values of 1.09 and –0.81 eÅ–3, respectively.
(dt, 3J = 8.6, J = 1.2 Hz, 2 H, 6-H Np), 7.50 (br. t, 2 H, 7-H Np),
4
3
3
7.07 (d, J = 8.9 Hz, 4 H, 2-H, 6-H Ph), 6.66 (d, J = 15.6 Hz, 2
H, 1-H vin), 6.43 (d, J = 8.9 Hz, 4 H, 3-H, 5-H Ph), 3.17 (t, 8 H,
3
NCH2), 1.54 (m, 8 H, CH2), 0.87 (t, 12 H, CH3) ppm. 13C NMR
(CDCl3, 100 MHz, 25 °C): δ = 150.0 (C-3, C-6 Pz), 148.2 (C-4 Ph),
146.9 (C-2, C-5 Pz), 136.4 (C-1 Np), 134.4 (C-2 vin), 133.8 (C-4a
Np), 132.0 (C-8a Np), 128.9 (C-4 Np), 128.7 (C-2, C-6 Ph), 128.3
(C-2 Np), 128.2 (C-5 Np), 126.5 (C-7 Np), 126.2 (C-8 Np), 126.0
(C-6 Np), 125.4 (C-3 Np), 124.0 (C-1Ph), 118.9 (C-1 vin), 111.2 (C-
CCDC-918792 (for 5) contains the supplementary crystallo-
graphic data for this paper. These data can be obtained free of
charge from The Cambridge Crystallographic Data Centre via
www.ccdc.cam.ac.uk/datarequest/cif.
3, C-5 Ph), 52.7 (NCH ), 20.4 (CH ), 11.3 (CH ) ppm. IR (ATR): ν
˜
2
2
3
= 2922, 2852, 1596, 1518, 1390, 1363, 1178, 1135, 968, 801,
776 cm–1. MS (FD): m/z (%) = 735.2 (100) [M]+. HRMS: calcd. for
C52H54N4 734.4348 [M]+; found 734.4332.
(E,E)-2,5-Bis{2-[4-(4Ј,7Ј,10Ј,13Ј-tetraoxa-1-azacyclopentadecyl)-
phenyl]ethenyl}-3,6-diphenylpyrazine (6): According to the pro-
cedure for 1, a solution of 17a (150 mg, 0.58 mmol), 18e (175 mg,
(E,E)-2,5-Bis{2-[4-(dipropylamino)phenyl]ethenyl}-3,6-bis(4-meth-
1.56 mmol), and KOtBu (100 mg, 1.78 mmol) in DMF (30 mL) oxyphenyl)pyrazine (9): According to the procedure for 1, a solution
gave 95 mg (0.11 mmol, 19%) of a red solid with m.p. 229–230 °C. of 17c (100 mg, 0.31 mmol), 18d (155 mg, 0.76 mmol), and KOtBu
1H NMR (CDCl3, 400 MHz, 25 °C): δ = 7.86–7.82 (m, 6 H, 2-H (170 mg, 1.52 mmol) in DMF (30 mL) gave 80 mg (0.12 mmol,
vin, 2-H, 6-H Ph-p), 7.56–7.47 (m, 6 H, 3-H, 4-H, 5-H Ph-p), 7.36
(d, J = 8.4 Hz, 4 H, 2-H, 6-H Ph), 7.12 (d, J = 15.6 Hz, 2 H, 1-
39 %) of a red solid with m.p. 205–208 °C. 1H NMR (CDCl3,
3
3
400 MHz, 25 °C): δ = 7.82 (d, 3J = 15.6 Hz, 2 H, 2-H vin), 7.79 (d,
12
www.eurjoc.org
© 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 0000, 0–0